Toggle navigation
Home
Search
Services
Blog
Contact
About
Apoptosis Inhibitors - Therapy for Neurotoxicity
Pulliam, Lynn
Neurex Corporation, Menlo Park, CA, United States
Search 44 grants from Lynn Pulliam
Search grants from Neurex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neuroinflammation in Diseases of the Central Nervous System
Targetable Exploratory Multinuclear MRI Contrast Agents
Improved Quantitative Accuracy of Spect-Pet Imaging
Structure-Function Analysis of Different C3 Species
Carbohydrate and Fat Metabolism During Exercise
Recently added grants:
Calcium signaling and ion channels in airway diseases
Immunoregulatory and effector roles of natural killer cell subsets
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis
Effect of sphingomyelin biosynthesis on atherosclerosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH056311-01
Application #
2256468
Study Section
Small Business Research Review Committee (MHSB)
Project Start
1996-08-01
Project End
1997-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Neurex Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Publications
Pulliam, L; Zhou, M; Stubblebine, M et al.
(1998)
Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor.
J Neurosci Res 54:530-8
Comments
Be the first to comment on Lynn Pulliam's grant